VentriPoint Diagnostics Ltd.
VPTDF
$0.123
$0.021821.54%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 672.41% | -- | 46.86% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 672.41% | -- | 46.86% | -- |
| Cost of Revenue | -- | -- | -- | -100.00% | 900.00% |
| Gross Profit | 1,046.00% | 672.41% | -- | 85.37% | -143.86% |
| SG&A Expenses | 25.94% | 16.28% | -12.36% | 38.49% | -40.03% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.28% | 22.84% | -14.74% | 12.13% | -20.18% |
| Operating Income | 1.06% | -20.60% | 14.50% | -11.26% | 19.32% |
| Income Before Tax | -4.77% | -24.95% | 11.31% | -11.76% | 18.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.77% | -24.95% | 11.31% | -11.76% | 18.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.77% | -24.95% | 11.31% | -11.76% | 18.68% |
| EBIT | 1.06% | -20.60% | 14.50% | -11.26% | 19.32% |
| EBITDA | 0.97% | -20.70% | 14.47% | -11.39% | 19.24% |
| EPS Basic | -3.57% | -24.53% | 11.11% | -11.54% | 18.84% |
| Normalized Basic EPS | -2.86% | -24.24% | 12.50% | -12.50% | 18.60% |
| EPS Diluted | -3.57% | -24.53% | 11.11% | -11.54% | 18.84% |
| Normalized Diluted EPS | -2.86% | -24.24% | 12.50% | -12.50% | 18.60% |
| Average Basic Shares Outstanding | 0.42% | 0.23% | 0.20% | 0.06% | 0.50% |
| Average Diluted Shares Outstanding | 0.42% | 0.23% | 0.20% | 0.06% | 0.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
